We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $32.4B
1-Year Est. Return 58.5%
This Fund
S&P 500
This Quarter Est. Return
+23.19%
1 Year Est. Return
+58.5%
3 Year Est. Return
+155.34%
5 Year Est. Return
+222.91%
10 Year Est. Return
AUM
$32.4B
AUM Growth
+$5.91B
Cap. Flow
+$1.91B
Cap. Flow %
5.91%
Top 10 Hldgs %
17.19%
Holding
1,187
New
164
Increased
545
Reduced
215
Closed
176

Sector Composition

Rank Sector Weight
1 Healthcare 25.1%
2 Technology 24.74%
3 Financials 10.96%
4 Consumer Discretionary 9.79%
5 Industrials 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RLAY icon
401
Relay Therapeutics
RLAY
$4.14B
$17.4M 0.05%
929,692
+250,350
+37% +$3.63M
CEG icon
402
Constellation Energy
CEG
$102B
$17.2M 0.05%
69,104
+8,208
+13% +$2.31M
HOOD icon
403
Robinhood
HOOD
$103B
$17.1M 0.05%
170,367
+78,308
+85% +$6.56M
LMT icon
404
Lockheed Martin
LMT
$121B
$17M 0.05%
33,382
-5,620
-14% -$3.04M
PBH icon
405
Prestige Consumer Healthcare
PBH
$2.22B
$17M 0.05%
359,721
+85,778
+31% +$4.41M
PLD icon
406
Prologis
PLD
$129B
$16.9M 0.05%
124,902
-177,045
-59% -$25.1M
VLO icon
407
Valero Energy
VLO
$114B
$16.9M 0.05%
64,925
+5,183
+9% +$1.28M
ORLY icon
408
O'Reilly Automotive
ORLY
$69.8B
$16.7M 0.05%
181,334
-301,619
-62% -$27.5M
COHR icon
409
Coherent
COHR
$59.6B
$16.6M 0.05%
42,122
+6,640
+19% +$2.35M
IBKR icon
410
Interactive Brokers
IBKR
$41.5B
$16.5M 0.05%
189,616
-165,133
-47% -$13.7M
OCUL icon
411
Ocular Therapeutix
OCUL
$2.35B
$16.4M 0.05%
1,667,609
MPC icon
412
Marathon Petroleum
MPC
$114B
$16.3M 0.05%
63,866
+5,866
+10% +$1.44M
ARWR icon
413
Arrowhead Research
ARWR
$12B
$16.3M 0.05%
200,184
INSM icon
414
Insmed
INSM
$27.8B
$16.3M 0.05%
152,618
+4,165
+3% +$504K
AEP icon
415
American Electric Power
AEP
$67.2B
$16.2M 0.05%
118,727
+13,055
+12% +$1.72M
PCVX icon
416
Vaxcyte
PCVX
$8.82B
$16M 0.05%
274,740
TXNM
417
TXNM Energy Inc
TXNM
$5.95B
$15.9M 0.05%
280,760
-133,083
-32% -$7.81M
LION icon
418
Lionsgate Studios
LION
$3.36B
$15.9M 0.05%
+1,039,909
New +$13.4M
NATL icon
419
NCR Atleos
NATL
$3.44B
$15.9M 0.05%
366,732
-173,054
-32% -$7.68M
CL icon
420
Colgate-Palmolive
CL
$69.4B
$15.8M 0.05%
172,483
-447,945
-72% -$39.2M
HSIC icon
421
Henry Schein
HSIC
$9.77B
$15.6M 0.05%
+187,236
New +$14.3M
MP icon
422
MP Materials
MP
$9.12B
$15.6M 0.05%
278,894
GMRS
423
GMR Solutions Inc
GMRS
$685M
$15.6M 0.05%
+1,010,224
New +$12.7M
CRH icon
424
CRH
CRH
$59.2B
$15.6M 0.05%
145,912
+14,627
+11% +$1.61M
PRVA icon
425
Privia Health
PRVA
$2.59B
$15.6M 0.05%
605,612
+129,657
+27% +$3M

Similar funds

Woodline Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Woodline Partners held 1,187 positions worth $32.4B, up 22% from $26.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Woodline Partners deployed $1.91B of net new capital in Q2 2026, opening 164 new positions and adding to 545 existing holdings. Its largest new stake was SpaceX: 508,235 shares worth $86.8M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Texas Instruments, an estimated $215M trimmed.

  • Woodline Partners's largest Q2 2026 buy was SpaceX: 508,235 shares worth $86.8M.
  • Woodline Partners added most to Meta Platforms (Facebook) in Q2 2026, an estimated $261M increase.
  • Woodline Partners's biggest Q2 2026 reduction was Texas Instruments, cutting an estimated $215M.
  • Woodline Partners fully exited SSR Mining in Q2 2026, selling an estimated $103M.
  • Woodline Partners's ten largest holdings make up 17% of its $32.4B portfolio in Q2 2026.
  • Woodline Partners opened 164 new positions and closed 176 in Q2 2026.
  • Woodline Partners's portfolio value rose 22% quarter-over-quarter to $32.4B.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.